At a glance: telemedicine and online pharmacy merchant accounts
- Typical rates (2026): 3.25% to 3.99% per transaction, depending on volume, risk and chargeback history
- Rolling reserve: often 5% to 10% of sales, held about 90 to 180 days and released on a schedule
- Typical approval time: about 5 to 10 business days once your application is complete
- Have ready: pharmacy and provider licenses, any pharmacy or telehealth certification you hold, government ID for each owner, business registration documents, and recent bank statements
- What underwriters check: a valid prescription process, licensed pharmacists and prescribers, card network registration, honest drug marketing and clear membership billing
Get a free quoteor call (888) 542-4147
A telemedicine and online pharmacy merchant account is a high-risk merchant account that lets telehealth practices, online pharmacies and prescription membership programs accept credit and debit cards. Because Visa and Mastercard treat card-not-present prescription drug sales as high integrity risk, the acquiring bank must underwrite, and often register, the business before it processes.
Paymotile is free to apply and works to match healthcare merchants with processors and acquiring banks that accept this category. Start your free application. This page explains payment rules only. It is not medical, legal or regulatory advice, so confirm your own obligations with qualified healthcare counsel. For other industries, see our high risk merchant account guide.
Why are telemedicine and online pharmacies considered high risk?
Banks rate them high risk because prescription drugs are tightly regulated, nearly every sale is card-not-present, and the card networks put extra rules on online pharmacy sales. Recurring memberships, compounded drug programs and cross-state licensing add dispute and legal exposure, so the acquirer must check the business carefully before approving it.
The main risk drivers are:
- Card network classification: Visa lists card-absent sales under MCC 5122 and 5912 as high integrity risk, and Mastercard requires acquirers to register non-face-to-face pharmaceutical merchants (details below).
- Prescription law: federal and state rules govern who may prescribe, how, and to which states. Controlled substances add DEA rules on top.
- Drug marketing: the FDA has been sending warning letters to telehealth companies over how they advertise compounded drugs.
- Memberships and subscriptions: patients who forget a monthly plan renews dispute the charge with their bank.
The account covers several business models, and each is underwritten differently:
| Business model | What is sold | What underwriters focus on |
|---|---|---|
| Telehealth consultation only | Virtual visits with licensed clinicians; prescriptions sent to an outside pharmacy | Provider licenses in each state served, consent and refund terms |
| Telehealth plus pharmacy | Visits plus medication shipped from a partner or owned pharmacy | Who sells the drug, pharmacy licenses, correct MCC for the medication line |
| Online pharmacy | Prescription fills shipped to patients | Pharmacy licenses, card network registration, accreditation or certification |
| Membership program | Monthly plans that bundle visits, coaching or medication | Recurring billing consent, cancellation flow, dispute history |
What do Visa and Mastercard require from online pharmacies?
Both networks single out card-not-present prescription sales. Visa treats card-absent sales under MCC 5122 and 5912 as high integrity risk, which requires acquirer registration unless the pharmacy is accredited by NABP or another regulatory body Visa recognizes. Mastercard requires acquirers to register non-face-to-face pharmaceutical merchants and verify they comply with the law.
The Visa Merchant Data Standards Manual (October 2026) lists card-absent transactions under MCC 5122 (Drugs, Drug Proprietaries, Druggist Sundries) and 5912 (Drug Stores, Pharmacies) as high integrity risk. Under the Visa Core Rules (October 24, 2026 edition), an acquirer must be approved by Visa and register its high integrity risk merchants before submitting their transactions. A footnote exempts merchants assigned MCC 5122 or 5912 that are accredited by the National Association of Boards of Pharmacy (NABP) or another regulatory body recognized by Visa.
Visa also bars accepting cards for products that “claim or imply a similar efficacy as prescription drugs,” which matters for non-prescription add-ons.
Mastercard’s Security Rules and Procedures, Merchant Edition (August 4, 2026) requires acquirers to register non-face-to-face pharmaceutical merchants and to verify that the merchant’s activity complies with applicable law. Ask your acquirer what proof of compliance it accepts and how often it rechecks it.
| Requirement | Visa | Mastercard |
|---|---|---|
| Which merchants | Card-absent sales under MCC 5122 and 5912 | Non-face-to-face pharmaceutical merchants |
| Registration | High integrity risk merchant registration by the acquirer | Registration by the acquirer |
| Third-party proof | NABP accreditation, or accreditation by another regulatory body Visa recognizes, exempts an MCC 5122 or 5912 merchant from registration | Acquirer must verify the merchant complies with applicable law; ask which proof it accepts |
| Ongoing monitoring | Daily activity monitoring by the acquirer | Set by the acquirer; ask how often it rechecks compliance |
Do you need pharmacy accreditation or third-party certification?
Often, in practice. Neither network’s public rules name a single certifier, but acquirers often want independent proof that a pharmacy or telehealth business operates legally. Visa’s rules exempt pharmacies accredited by NABP or another regulatory body Visa recognizes from merchant registration. Ask your acquirer which accreditation or certification it accepts before you apply.
Neither network’s public rule text names a certifier, and the Visa and Mastercard rules described above are written around pharmacy MCCs. In practice, acquirers often ask telehealth businesses that sell medication for NABP accreditation or for certification from a private certification company such as LegitScript. Consultation-only practices may be asked too, so ask your acquirer which proof it accepts.
Which MCC codes do telehealth and pharmacy merchants use?
Retail pharmacies use MCC 5912 (Drug Stores and Pharmacies), and wholesale drug distributors use 5122. Physician practices use 8011, and other medical services use 8099. If one business sells both consultations and medication, Visa expects the high integrity risk line to carry its own high-risk MCC.
| MCC | Visa title | Typical telehealth or pharmacy use |
|---|---|---|
| 5912 | Drug Stores and Pharmacies | Retail sale of prescription and proprietary drugs, including online pharmacies |
| 5122 | Drugs, Drug Proprietaries, and Druggist Sundries | Business-to-business or wholesale distribution of drugs |
| 8011 | Doctors and Physicians (Not Elsewhere Classified) | Licensed physician practices, including virtual visits |
| 8099 | Medical Services and Health Practitioners (Not Elsewhere Classified) | Other medical services and health practitioners |
The Visa manual says a merchant with multiple lines of business, one of which is high integrity risk, must assign a high integrity risk MCC to that line and a different MCC to the rest. A platform that bills for a visit and ships medication may therefore need two MCCs. Your acquirer assigns the final codes.
How do the Ryan Haight Act and DEA telemedicine rules affect payments?
The Ryan Haight Act generally requires an in-person medical evaluation before a controlled substance is prescribed over the internet. DEA and HHS have extended a temporary exception through December 31, 2026. Underwriters ask whether you prescribe controlled substances because a rule change could force you to stop selling overnight.
- The law: 21 U.S.C. 829(e) bars dispensing controlled substances by means of the internet without a valid prescription, which generally requires at least one in-person medical evaluation, subject to listed telemedicine exceptions.
- Current flexibility: the DEA and HHS fourth temporary extension (published December 31, 2025) continues the telemedicine flexibilities for prescribing controlled medications through December 31, 2026.
- Pending rule: the DEA’s special registration for telemedicine proposal (January 17, 2025) had not been finalized as of November 12, 2026. Check for a new extension or final rule before January 1, 2027.
The Act covers controlled substances only. If you prescribe them, expect questions about your plan for 2027.
Can you accept cards for compounded GLP-1 programs?
Some acquirers accept GLP-1 telehealth programs, but compounded GLP-1s get the closest review in this category. The FDA says compounded drugs are not FDA-approved, has warned telehealth companies about misleading claims, and has proposed keeping semaglutide, tirzepatide and liraglutide off the 503B bulks list.
- Not FDA-approved: the FDA states that compounded drugs are not FDA approved (page current as of October 1, 2026), and it reports 990 adverse event reports for compounded semaglutide and more than 730 for compounded tirzepatide as of May 31, 2026.
- Warning letters: on March 3, 2026 the FDA announced 30 warning letters to telehealth companies over claims implying compounded GLP-1 products are the same as FDA-approved drugs, and over branding that hides who compounds the product.
- 503B bulks proposal: in a May 1, 2026 notice, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the list of bulk substances outsourcing facilities may compound with. No final decision had been published in the Federal Register as of November 12, 2026.
The FDA’s page on what telehealth companies should know when promoting compounded drugs (June 15, 2026) lists claims it considers false or misleading, such as calling a compounded drug generic or “the same as” an approved drug, calling it FDA-approved, claiming it is clinically proven to match an approved drug, or describing a pharmacy as FDA-approved or FDA-licensed. Acquirers may review your website for the same claims. Name the dispensing pharmacy and keep its licenses on file.
Does HIPAA apply to payment processing?
HIPAA’s rules do not apply to a financial institution’s ordinary payment processing, such as authorizing and settling a card payment for health care. Your practice still has HIPAA duties, so keep diagnoses and treatment details out of billing descriptors, receipts and payment notes, and share only what a payment requires.
The exemption is in 42 U.S.C. 1320d-8, which covers use or disclosure of information to process payments for health care, including by credit or debit card. It protects the bank’s payment activities; it does not change what your practice owes patients. Card data security falls under the separate PCI DSS standard. A neutral descriptor, such as your brand name and support phone number, also cuts “unrecognized charge” disputes.
How should telehealth memberships be billed?
Treat a membership like any card subscription: show the price and renewal terms before checkout, get clear consent, email a receipt with a cancellation link, and make cancelling as easy as signing up. Unclear renewal terms and hard-to-find cancellation steps tend to lead to disputes.
Federal ROSCA rules, state auto-renewal laws and Visa’s subscription rules all apply to recurring plans. Our subscription merchant account guide covers the consent, reminder and cancellation steps in detail. Keep medication refills tied to an active prescription, and do not bill for shipments a clinician has not authorized.
What documents do you need to apply?
Expect a heavier file than most high-risk merchants: business and owner documents, financials, plus licenses for the pharmacy and every prescriber, any certification you hold, your prescribing workflow and your website claims. A complete file is the fastest route to approval.
- Business registration documents, EIN and a business bank account
- Government ID for each owner
- Recent bank statements, plus recent processing statements if you have them
- Pharmacy licenses for each state you ship to, and DEA registration if you dispense controlled substances
- A list of prescribing clinicians with license numbers and states, or your contract with a clinician network
- Any NABP accreditation or third-party certification you hold
- Agreements with any partner or compounding pharmacy that dispenses for you
- A live website with pricing, membership terms, refund and cancellation policy, privacy policy and contact details
- Screenshots of the intake, checkout and cancellation flow
Our high-risk merchant account setup guide walks through the rest. With a complete file, approval typically takes about 5 to 10 business days.
What does a telemedicine merchant account cost?
As of 2026, typical high-risk rates run 3.25% to 3.99% per transaction, depending on volume, risk and chargeback history. Most accounts carry a rolling reserve of about 5% to 10% of sales, held about 90 to 180 days. Your product mix and dispute history set where you land in those ranges.
A rolling reserve holds a share of each day’s sales as a cushion against refunds and chargebacks, then releases it on a schedule. Get every fee in writing.
What chargeback rate gets a telehealth account shut down?
Since April 1, 2026, Visa’s VAMP program flags a US merchant as excessive at 1.5% or higher, counting fraud and disputes over settled card-not-present transactions, once the merchant has at least 1,500 combined reports in a month. Your bank can act well below that line.
The Visa Acquirer Monitoring Program also measures the acquirer’s whole portfolio. If that portfolio is over Visa’s thresholds, the bank may act on merchants well below 1.5%, so a bank holding many healthcare merchants watches each one closely. See our VAMP explainer and chargeback prevention tools.
How do you apply through Paymotile?
Apply once, free. Paymotile is a high-risk merchant account agent, not a bank: we review your file for gaps, then match your telehealth or pharmacy business with processors and acquiring banks that accept your products, billing model and volume. Approval is never guaranteed, but a complete file moves fastest.
- Complete the free application or call (888) 542-4147.
- Tell us your model: consultations only, pharmacy, compounded products, controlled substances, memberships.
- Send the documents listed above, including licenses and any certification.
- We flag gaps in your website claims, MCC setup or billing flow before submission.
- Review the offer, sign, integrate your gateway and start processing.
If Stripe, PayPal or Square closed your account, bring the termination notice and a chargeback summary. For supplement-only brands, see our nutraceutical merchant account guide.
Telemedicine and pharmacy merchant account FAQ
Is a telemedicine merchant account different from a pharmacy merchant account?
Often, yes. A consultation-only practice is usually coded as a medical service, while any business selling prescription drugs card-not-present falls under pharmacy MCCs and the networks’ extra pharmacy rules. Many telehealth brands need both.
Can I process payments for GLP-1 telehealth programs?
Some acquirers accept them case by case. Expect questions about the dispensing pharmacy, prescriber licenses, whether products are FDA-approved or compounded, and whether your marketing avoids the claims the FDA lists on its compounded drug promotion page.
Do I need third-party certification to get approved?
Not in every case, but many acquirers ask for third-party certification or NABP accreditation, especially for online pharmacies and telehealth brands that sell medication.
What happens to my account if the DEA telemedicine flexibilities expire?
Your merchant account is not tied to the DEA rule, but prescribing controlled substances without an in-person visit is. Tell your processor before you change what you prescribe.
How long does approval take?
About 5 to 10 business days once the application is complete. Missing licenses, unclear pharmacy relationships and drug claims on the website can slow underwriting.
Related guides: what a merchant account is, merchant account fees, the Visa VAMP chargeback threshold and the MATCH list.
Sources
Statistics and legal references in this guide come from the sources below. We review them regularly and update the page when newer data is published.
- Visa, Visa Core Rules and Visa Product and Service Rules (October 24, 2026).
- Visa, Visa Merchant Data Standards Manual (October 2026).
- Mastercard, Security Rules and Procedures, Merchant Edition (August 4, 2026).
- Legal Information Institute, 21 U.S.C. 829, Prescriptions.
- Drug Enforcement Administration and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (December 31, 2025).
- Drug Enforcement Administration, Special Registrations for Telemedicine and Limited State Telemedicine Registrations (proposed rule) (January 17, 2025).
- U.S. Food and Drug Administration, FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of October 1, 2026).
- U.S. Food and Drug Administration, FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s (March 3, 2026).
- U.S. Food and Drug Administration, FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs (content current as of June 15, 2026).
- U.S. Food and Drug Administration, List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the FD&C Act (May 1, 2026).
- Legal Information Institute, 42 U.S.C. 1320d-8, Applicability to financial institutions.
- PCI Security Standards Council, PCI Data Security Standard (PCI DSS).
- Visa, Visa Acquirer Monitoring Program Overview (fact sheet) (2025).